Over twenty states and the District of Columbia have laws allowing the use of medical cannabis. As use of medical cannabis increases, many pharmacists are considering what role they may play in caring for patients who use medical cannabis.
In this archived webinar, an expert in the field will discuss the potential mechanisms of action of cannabis, various formulations and uses for cannabis, patient safety issues including potential drug interactions, and communication strategies for discussing cannabis use with patients. There are many implications medical cannabis could have for the profession of pharmacy, and pharmacists should be equipped to respond to patients considering the use of cannabis.
After participating in "The Implications of Medical Cannabis for the Practice of Pharmacy (Home Study)", the pharmacist will be able to:
1. Describe the current regulatory status of cannabis in the United States.
2. Describe the clinical pharmacology of cannabis and its active components.
3. Evaluate clinical studies that have been performed in patients with various conditions using cannabis.
4. Identify potential drug interactions and other patient safety issues that may occur with the use of cannabis.
5. Discuss communication strategies for talking with patients who are using medical cannabis.
Activity Type: Knowledge-based
Target Audience: Pharmacists
Learning Level: Level 2
To obtain 1.0 contact hour of CPE credit (0.1 CEUs) for "The Implications of Medical Cannabis for the Practice of Pharmacy (Home Study)" complete the assessment with a grade of 70% or better, complete the evaluation and CLAIM credit. Participants will need to have a valid pharmacist.com username and password to claim credit. After your credit has been claimed, please visit CPE monitor for your transcript.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education examination. Please note that you will not be permitted to submit the examination a third time. All exam questions are randomized and may not appear in the same order as printed. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests.
Initial Release Date: June 14, 2017
Expiration Date: June 14, 2020
"The Implications of Medical Cannabis for the Practice of Pharmacy (Home Study)" is an archived webinar education activity for pharmacists developed by the American Pharmacists Association.
Laura M. Borgelt, PharmD, FCCP, BCPS declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.
APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures. Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
There is no fee for APhA Members and $129 for non-members. This online educational activity is available exclusively to APhA members for the first 30 days of release, as a free member benefit. Thereafter, non-members can purchase this activity at a cost of $129.
Computer and Internet access is required to complete this activity. Please visit our website to view the Technology System Requirements to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-17-163-H04-P||0.1 CEUs||June 14, 2017 - June 14, 2020|